Chordate Medical Holding AB (publ)

Stockholm Stock Exchange CMH.ST

Chordate Medical Holding AB (publ) Net Income Margin for the year ending December 31, 2023: -2,989.58%

Chordate Medical Holding AB (publ) Net Income Margin is -2,989.58% for the year ending December 31, 2023, a 88.39% change year over year. Net Income Ratio, also known as the profit margin, is the ratio of net income to net sales, showing the percentage of revenue that remains as profit after all expenses are deducted.
  • Chordate Medical Holding AB (publ) Net Income Margin for the year ending December 31, 2022 was -25,749.85%, a -943.47% change year over year.
  • Chordate Medical Holding AB (publ) Net Income Margin for the year ending December 31, 2021 was -2,467.70%, a 22.82% change year over year.
  • Chordate Medical Holding AB (publ) Net Income Margin for the year ending December 31, 2020 was -3,197.19%, a -49.49% change year over year.
  • Chordate Medical Holding AB (publ) Net Income Margin for the year ending December 31, 2019 was -2,138.75%, a 24.25% change year over year.
Key data
Date Net Income Margin EBITDA Margin EBIT Margin EBITDA
Market news
Stockholm Stock Exchange: CMH.ST

Chordate Medical Holding AB (publ)

CEO Mr. Anders Weilandt
IPO Date Feb. 15, 2022
Location Sweden
Headquarters KistagAngen 20B
Employees 3
Sector Health Care
Industries
Pharmaceuticals
Description

Chordate Medical Holding AB (publ), a medical technology company, develops products and solutions for the treatment of chronic migraine and rhinitis in Sweden. It focuses on the ear-nose and throat area. The company was founded in 2005 and is based in Kista, Sweden.

Similar companies

CLS-B.ST

Clinical Laserthermia Systems AB (publ)

USD 0.28

-7.61%

StockViz Staff

January 15, 2025

Any question? Send us an email